145 related articles for article (PubMed ID: 20196632)
21. Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2.
Azevedo MA; Bourbon AI; Vicente AA; Cerqueira MA
Int J Biol Macromol; 2014 Nov; 71():141-6. PubMed ID: 24863916
[TBL] [Abstract][Full Text] [Related]
22. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
[TBL] [Abstract][Full Text] [Related]
23. Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan.
Lee KW; Yoon JJ; Lee JH; Kim SY; Jung HJ; Kim SJ; Joh JW; Lee HH; Lee DS; Lee SK
Transplant Proc; 2004 Oct; 36(8):2464-5. PubMed ID: 15561282
[TBL] [Abstract][Full Text] [Related]
24. Quaternized chitosan/alginate nanoparticles for protein delivery.
Li T; Shi XW; Du YM; Tang YF
J Biomed Mater Res A; 2007 Nov; 83(2):383-90. PubMed ID: 17450586
[TBL] [Abstract][Full Text] [Related]
25. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Chen F; Zhang ZR; Huang Y
Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
[TBL] [Abstract][Full Text] [Related]
26. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads.
Pasparakis G; Bouropoulos N
Int J Pharm; 2006 Oct; 323(1-2):34-42. PubMed ID: 16828245
[TBL] [Abstract][Full Text] [Related]
27. Effect of chitosan-alginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells.
Yang SJ; Chang SM; Tsai KC; Chen WS; Lin FH; Shieh MJ
J Gene Med; 2010 Feb; 12(2):168-79. PubMed ID: 19943342
[TBL] [Abstract][Full Text] [Related]
28. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin.
Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF
Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028
[TBL] [Abstract][Full Text] [Related]
29. Development of a new calcium sulphate-based composite using alginate and chemically modified chitosan for bone regeneration.
d'Ayala GG; De Rosa A; Laurienzo P; Malinconico M
J Biomed Mater Res A; 2007 Jun; 81(4):811-20. PubMed ID: 17236217
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of aligned hematite nanoparticles on chitosan-alginate films.
Sreeram KJ; Nidhin M; Nair BU
Colloids Surf B Biointerfaces; 2009 Jul; 71(2):260-7. PubMed ID: 19303261
[TBL] [Abstract][Full Text] [Related]
32. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
33. Injectable in situ forming nanogel: A hybrid Alginate-NLC formulation extends bupivacaine anesthetic effect.
Rodrigues da Silva GH; Geronimo G; Ribeiro LNM; Guilherme VA; de Moura LD; Bombeiro AL; Oliveira JD; Breitkreitz MC; de Paula E
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110608. PubMed ID: 32228992
[TBL] [Abstract][Full Text] [Related]
34. Bupivacaine containing dry emulsion can prolong epidural anesthetic effects in rabbits.
Dollo G; Le Corre P; Chevanne F; Le Verge R
Eur J Pharm Sci; 2004 May; 22(1):63-70. PubMed ID: 15113584
[TBL] [Abstract][Full Text] [Related]
35. Local neurotoxicity and myotoxicity evaluation of cyclodextrin complexes of bupivacaine and ropivacaine.
Cereda CM; Tofoli GR; Maturana LG; Pierucci A; Nunes LA; Franz-Montan M; de Oliveira AL; Arana S; de Araujo DR; de Paula E
Anesth Analg; 2012 Nov; 115(5):1234-41. PubMed ID: 22822189
[TBL] [Abstract][Full Text] [Related]
36. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
Zhang N; Li J; Jiang W; Ren C; Li J; Xin J; Li K
Int J Pharm; 2010 Jun; 393(1-2):212-8. PubMed ID: 20394813
[TBL] [Abstract][Full Text] [Related]
37. Aging and microwave effects on alginate/chitosan matrices.
Wong TW; Chan LW; Kho SB; Heng PW
J Control Release; 2005 Jun; 104(3):461-75. PubMed ID: 15911046
[TBL] [Abstract][Full Text] [Related]
38. Long acting local anesthetic-polymer formulation to prolong the effect of analgesia.
Shikanov A; Domb AJ; Weiniger CF
J Control Release; 2007 Jan; 117(1):97-103. PubMed ID: 17137669
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of sodium alginate as drug release modifier in matrix tablets.
Liew CV; Chan LW; Ching AL; Heng PW
Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterisation of alginate/chitosan nanoparticles as tamoxifen controlled delivery systems.
Martínez A; Arana P; Fernández A; Olmo R; Teijón C; Blanco MD
J Microencapsul; 2013; 30(4):398-408. PubMed ID: 23489017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
